Stockreport

Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights [Yahoo! Finance]

Biodesix, Inc.  (BDSX) 
PDF Biodesix, Inc. Delivered 41% revenue growth and 83% gross margin in Q4 2025; Improved Net Loss by 52% and achieved first-ever Adjusted EBITDA positivity in Q4 2025; [Read more]